Quince Therapeutics, Inc. current report, 08 June 2020

Full document

Business Context and Reporting Period

This Form 8-K filing by Cortexyme, Inc. (not Quince Therapeutics, Inc.) reports on the Annual Meeting of Stockholders held on June 8, 2020. The meeting was conducted via live audio webcast. The filing does not contain financial performance data, revenue, or operational metrics for a specific reporting period.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.

Material Changes and Voting Results

The primary material event reported is the outcome of the Annual Meeting. Stockholders representing approximately 80.4% of eligible shares (23,651,943 shares) participated. Two proposals were approved:

  • Proposal One (Election of Directors): Stockholders approved the election of two Class I directors for three-year terms:
    • Margaret A. McLoughlin, Ph.D.: 18,955,090 votes for; 285,674 votes withheld; 4,411,179 broker non-votes.
    • Una Ryan, OBE, Ph.D.: 18,955,390 votes for; 285,374 votes withheld; 4,411,179 broker non-votes.
  • Proposal Two (Ratification of Accounting Firm): Stockholders ratified the appointment of BDO USA, LLP as the independent registered accounting firm for the fiscal year ending December 31, 2020.
    • Votes For: 23,646,436
    • Votes Against: 4,650
    • Abstentions: 857

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a disclosure of voting results.

Investor Verification Checklist

  • Verify the correct registrant name is Cortexyme, Inc. (Ticker: CRTX), as the input metadata incorrectly referenced Quince Therapeutics.
  • Confirm the appointment of BDO USA, LLP as the auditor for the fiscal year ending December 31, 2020.
  • Note the high level of broker non-votes (4,411,179) on the director election, which may indicate significant institutional holdings.
  • Review the Company's 10-K or 10-Q filings for actual financial performance data, as this 8-K does not contain such information.